Lymphomatosis Cerebri: A Diagnostic Challenge

JAMA Neurol. 2015 Sep;72(9):1066-7. doi: 10.1001/jamaneurol.2015.1149.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use
  • Brain Neoplasms / complications
  • Brain Neoplasms / diagnosis*
  • Brain Neoplasms / drug therapy
  • DNA-Binding Proteins / genetics
  • Female
  • Frontal Lobe / pathology*
  • Humans
  • Immunocompetence
  • Levetiracetam
  • Lymphoma / complications
  • Lymphoma / diagnosis*
  • Lymphoma / drug therapy
  • Magnetic Resonance Imaging
  • Nootropic Agents
  • Piracetam / analogs & derivatives
  • Piracetam / therapeutic use
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-6
  • Spasm / etiology

Substances

  • Antineoplastic Agents
  • BCL2 protein, human
  • BCL6 protein, human
  • DNA-Binding Proteins
  • Nootropic Agents
  • Proto-Oncogene Proteins c-bcl-2
  • Proto-Oncogene Proteins c-bcl-6
  • Levetiracetam
  • Piracetam